×
About 46,351 results

ALLMedicine™ Fatty Liver Center

Research & Reviews  22,187 results

Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CAR...
https://doi.org/10.1186/s12876-021-01681-0 10.1001/jamacardio.2019.4187 10.1159/000109998 10.1016/S1474-4422(09)70299-6 10.1136/bmj.d7622 10.3758/s13423-015-0910-8 10.1016/S1474-4422(06)70537-3 10.1136/jnnp.2009.176818 10.1111/j.1532-5415.2012.04081.x 10.1161/CIRCULATIONAHA.113.004798 10.1212/WNL.0b013e318227b227 10.1212/WNL.0000000000010078 10.1161/CIRCULATIONAHA.114.008906 10.1038/nrgastro.2013.171 10.1111/j.1365-2036.2011.04724.x 10.1002/hep.28431 10.1016/j.cld.2012.05.008 10.1016/j.cgh.2011.12.039 10.1002/hep.22371 10.1002/hep.22752 10.1161/01.ATV.0000160613.57985.18 10.1016/j.jns.2004.05.012 10.1016/j.atherosclerosis.2011.07.013 10.1002/oby.21767 10.1001/jamaneurol.2017.3229 10.1212/WNL.0000000000002498 10.1111/liv.14161 10.1016/0895-4356(88)90080-7 10.1002/hep.27869 10.1016/j.atherosclerosis.2014.05.962 10.1212/WNL.0000000000007243 10.1161/ATVBAHA.117.309633 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4 10.1037/h0054651 10.1037/0033-2909.109.2.163 10.1097/00001648-200009000-00011 10.1016/j.dld.2019.05.015 10.1056/NEJMra0912063 10.3389/fnagi.2019.00174 10.1016/j.jalz.2015.06.1885 10.1002/cld.716 10.1002/hep.25762 10.1037/a0032468 10.1037/neu0000044 10.1093/eurheartj/ehn298
BMC Gastroenterology; Gerber Y, VanWagner LB et. al.

Mar 3rd, 2021 - Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD) risk factors that have been linked to cognitive decline. Whether NAFLD is associated with cognitive performance in midlife remains uncertain. Coronary Artery...

Comparison between non-invasive methods and liver histology to stratify liver fibrosis ...
https://doi.org/10.1016/j.orcp.2021.02.004
Obesity Research & Clinical Practice; Didoné Filho CN, Reginatto CJ et. al.

Mar 2nd, 2021 - Obesity is a multifactorial disease characterized by fat accumulation, usually associated with non-alcoholic fatty liver disease, which can lead to advanced fibrosis or even cirrhosis. Bariatric surgery (BS) is a treatment approved for weight loss...

Serum fetuin-A and Ser312 phosphorylated fetuin-A responses and markers of insulin sens...
https://doi.org/10.14814/phy2.14773
Physiological Reports; Ren G, Bowers RL et. al.

Mar 2nd, 2021 - Fetuin-A (Fet-A), secreted by the liver and adipose tissue, inhibits insulin receptor tyrosine kinase activity and modulates insulin action. Numerous studies have shown association of elevated serum Fet-A concentrations with obesity, non-alcoholic...

Bioinformatics analysis of differentially expressed proteins in alcoholic fatty liver d...
https://doi.org/10.3892/mmr.2021.11929
Molecular Medicine Reports; Zhang ZR, Yang ZG et. al.

Mar 2nd, 2021 - Cytoglobin (Cygb) is a globin molecule that is ubiquitously expressed in all tissues and has a protective role under oxidative stress. It has also been demonstrated to be effective in the treatment of alcoholic fatty liver disease (AFLD). In order...

Neutrophil-Induced Liver Injury and Interactions Between Neutrophils and Liver Sinusoid...
https://doi.org/10.1007/s10753-021-01442-x 10.1161/CIRCRESAHA.116.309692 10.1152/physrev.00012.2018 10.1146/annurev-immunol-020711-074942 10.1152/ajpgi.00058.2013 10.1038/nri.2017.105 10.4049/jimmunol.1601773 10.1038/nm.2507 10.1038/nrgastro.2012.225 10.1080/08941930152024228 10.4049/jimmunol.1100490 10.1097/00007890-200206150-00007 10.1006/jsre.2000.5884 10.1055/s-0038-1636529 10.1002/hep.510230649 10.1007/s11427-019-1596-4 10.3389/fimmu.2018.02610 10.1097/00007890-199610150-00008 10.1159/000049730 10.1097/00003246-199611000-00023 10.1002/hep.27841 10.1002/jcp.26167 10.1001/jama.2015.5370 10.1053/j.gastro.2010.09.038 10.1038/nrgastro.2013.171 10.1007/s12020-017-1323-4 10.1016/j.jcmgh.2018.01.003 10.1007/s12013-015-0682-9 10.1371/journal.pone.0052411 10.1002/hep.29914 10.1016/j.tox.2011.10.005 10.1016/j.clinre.2016.04.003 10.1124/jpet.107.122069 10.1002/bjs.5625 10.1124/jpet.105.087981 10.1016/S0168-8278(00)80219-6 10.1111/j.1600-0676.1987.tb00366.x 10.1152/ajpgi.00031.2015 10.1111/j.1365-2249.2012.04609.x 10.1016/j.taap.2004.12.018 10.1002/path.1917 10.1097/00042737-199602000-00008 10.1002/eji.201646394 10.1016/j.jhep.2013.12.005 10.1002/hep.25801 10.1111/j.1478-3231.2010.02284.x 10.1002/hep.21175 10.1016/j.cgh.2015.07.019 10.21037/atm-2020-90 10.1002/hep.25907 10.1186/s13046-015-0247-1 10.1016/j.jhep.2010.08.041 10.1158/0008-5472.CAN-05-1734 10.1038/nm.2084 10.1038/ncomms7818 10.1177/1076029618825310 10.1186/s13045-019-0836-0 10.3389/fimmu.2017.00464 10.1016/j.jhep.2017.11.010 10.1128/JVI.79.24.15142-15150.2005 10.4049/jimmunol.172.1.45 10.1152/ajplung.2000.279.6.L1005 10.1126/science.1099320 10.1089/ars.2007.1509 10.1161/01.HYP.0000196727.53300.62 10.1002/jlb.52.4.377 10.1002/hep.510290222 10.1155/2018/4780615 10.1016/0376-8716(91)90063-5 10.1016/j.jhep.2005.07.034 10.1016/j.jep.2010.01.043 10.1152/ajpgi.2000.278.5.G693 10.1002/hep.510250218 10.1016/j.fsi.2018.10.084 10.1016/j.taap.2010.08.025 10.1074/jbc.M701759200 10.1083/jcb.201203170 10.4049/jimmunol.1201719 10.1053/j.gastro.2019.03.013 10.1038/ncomms7673 10.1038/nm.2053 10.1371/journal.pone.0032366 10.1016/j.micinf.2003.09.008 10.1016/j.trsl.2010.02.003 10.1002/jlb.61.6.647 10.1083/jcb.107.6.2117 10.1002/jlb.59.5.716 10.2741/3462 10.1016/S0014-5793(03)00482-4 10.1152/ajpgi.00342.2002 10.1096/fj.03-0708fje 10.1023/A:1022344031223 10.1189/jlb.1012540 10.1111/imm.13005 10.1126/science.1195491 10.4049/jimmunol.1000332 10.1016/S0002-9440(10)61701-4 10.3389/fphys.2019.00006 10.1084/jem.20041035 10.1016/j.biocel.2015.02.017 10.1172/JCI119468 10.4049/jimmunol.173.12.7594 10.1084/jem.20071765 10.1002/hep.510290505 10.1182/blood.V80.8.2012.2012 10.1038/nrgastro.2017.183 10.1002/jlb.63.3.288 10.1152/ajpgi.00312.2005 10.1002/hep.510280324 10.1053/j.gastro.2009.12.008 10.1152/ajpgi.2001.281.5.G1188 10.1152/ajpgi.00318.2003 10.1046/j.1440-1746.2000.02207.x 10.1007/s10353-015-0363-3 10.1371/journal.pone.0032785 10.1111/jgh.14612 10.1016/j.coph.2011.06.007 10.1002/hep.510250324 10.1046/j.1440-1746.2000.02224.x 10.3748/wjg.v8.i2.342 10.1016/S0168-8278(97)80316-9 10.1111/j.1572-0241.1999.01541.x 10.1016/j.jhep.2012.09.008 10.1016/j.jhep.2019.02.012
Inflammation Wang Y, Liu Y

Mar 2nd, 2021 - Neutrophils are the most abundant type of leukocytes with diverse functions in immune defense including production of reactive oxygen species, bacteriocidal proteins, neutrophil extracellular traps, and pro-inflammatory mediators. However, aberran...

see more →

Guidelines  53 results

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

Latin American Association for the study of the liver (ALEH) practice guidance for the ...
https://doi.org/10.1016/j.aohep.2020.09.006
Annals of Hepatology; Arab JP, Dirchwolf M et. al.

Oct 8th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052356/
Frontiers in Pharmacology; Gisondi P,et al

Feb 24th, 2020 - Psoriasis is a chronic, systemic immune-mediated disease characterized by development of erythematous, indurated, scaly, pruritic plaques on the skin. Psoriasis is frequently associated to comorbidities, including psoriatic arthritis, cardiovascul...

Non-alcoholic fatty liver disease
https://ghr.nlm.nih.gov/condition/non-alcoholic-fatty-liver-disease
NIH - Genetics Home Reference;

Feb 10th, 2020 - Non-alcoholic fatty liver disease (NAFLD) is a buildup of excessive fat in the liver that can lead to liver damage resembling the damage caused by alcohol abuse, but that occurs in people who do not drink heavily.

ACG Clinical Guideline: Hereditary Hemochromatosis
https://journals.lww.com/ajg/Fulltext/2019/08000/ACG_Clinical_Guideline__Hereditary_Hemochromatosis.11.aspx
Kowdley,K.,et al

Aug 1st, 2019 - Hereditary hemochromatosis (HH) is one of the most common genetic disorders among persons of northern European descent. There have been recent advances in the diagnosis, management, and treatment of HH. The availability of molecular diagnostic tes...

see more →

Clinicaltrials.gov  22,981 results

Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CAR...
https://doi.org/10.1186/s12876-021-01681-0 10.1001/jamacardio.2019.4187 10.1159/000109998 10.1016/S1474-4422(09)70299-6 10.1136/bmj.d7622 10.3758/s13423-015-0910-8 10.1016/S1474-4422(06)70537-3 10.1136/jnnp.2009.176818 10.1111/j.1532-5415.2012.04081.x 10.1161/CIRCULATIONAHA.113.004798 10.1212/WNL.0b013e318227b227 10.1212/WNL.0000000000010078 10.1161/CIRCULATIONAHA.114.008906 10.1038/nrgastro.2013.171 10.1111/j.1365-2036.2011.04724.x 10.1002/hep.28431 10.1016/j.cld.2012.05.008 10.1016/j.cgh.2011.12.039 10.1002/hep.22371 10.1002/hep.22752 10.1161/01.ATV.0000160613.57985.18 10.1016/j.jns.2004.05.012 10.1016/j.atherosclerosis.2011.07.013 10.1002/oby.21767 10.1001/jamaneurol.2017.3229 10.1212/WNL.0000000000002498 10.1111/liv.14161 10.1016/0895-4356(88)90080-7 10.1002/hep.27869 10.1016/j.atherosclerosis.2014.05.962 10.1212/WNL.0000000000007243 10.1161/ATVBAHA.117.309633 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4 10.1037/h0054651 10.1037/0033-2909.109.2.163 10.1097/00001648-200009000-00011 10.1016/j.dld.2019.05.015 10.1056/NEJMra0912063 10.3389/fnagi.2019.00174 10.1016/j.jalz.2015.06.1885 10.1002/cld.716 10.1002/hep.25762 10.1037/a0032468 10.1037/neu0000044 10.1093/eurheartj/ehn298
BMC Gastroenterology; Gerber Y, VanWagner LB et. al.

Mar 3rd, 2021 - Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD) risk factors that have been linked to cognitive decline. Whether NAFLD is associated with cognitive performance in midlife remains uncertain. Coronary Artery...

Comparison between non-invasive methods and liver histology to stratify liver fibrosis ...
https://doi.org/10.1016/j.orcp.2021.02.004
Obesity Research & Clinical Practice; Didoné Filho CN, Reginatto CJ et. al.

Mar 2nd, 2021 - Obesity is a multifactorial disease characterized by fat accumulation, usually associated with non-alcoholic fatty liver disease, which can lead to advanced fibrosis or even cirrhosis. Bariatric surgery (BS) is a treatment approved for weight loss...

Serum fetuin-A and Ser312 phosphorylated fetuin-A responses and markers of insulin sens...
https://doi.org/10.14814/phy2.14773
Physiological Reports; Ren G, Bowers RL et. al.

Mar 2nd, 2021 - Fetuin-A (Fet-A), secreted by the liver and adipose tissue, inhibits insulin receptor tyrosine kinase activity and modulates insulin action. Numerous studies have shown association of elevated serum Fet-A concentrations with obesity, non-alcoholic...

Bioinformatics analysis of differentially expressed proteins in alcoholic fatty liver d...
https://doi.org/10.3892/mmr.2021.11929
Molecular Medicine Reports; Zhang ZR, Yang ZG et. al.

Mar 2nd, 2021 - Cytoglobin (Cygb) is a globin molecule that is ubiquitously expressed in all tissues and has a protective role under oxidative stress. It has also been demonstrated to be effective in the treatment of alcoholic fatty liver disease (AFLD). In order...

Neutrophil-Induced Liver Injury and Interactions Between Neutrophils and Liver Sinusoid...
https://doi.org/10.1007/s10753-021-01442-x 10.1161/CIRCRESAHA.116.309692 10.1152/physrev.00012.2018 10.1146/annurev-immunol-020711-074942 10.1152/ajpgi.00058.2013 10.1038/nri.2017.105 10.4049/jimmunol.1601773 10.1038/nm.2507 10.1038/nrgastro.2012.225 10.1080/08941930152024228 10.4049/jimmunol.1100490 10.1097/00007890-200206150-00007 10.1006/jsre.2000.5884 10.1055/s-0038-1636529 10.1002/hep.510230649 10.1007/s11427-019-1596-4 10.3389/fimmu.2018.02610 10.1097/00007890-199610150-00008 10.1159/000049730 10.1097/00003246-199611000-00023 10.1002/hep.27841 10.1002/jcp.26167 10.1001/jama.2015.5370 10.1053/j.gastro.2010.09.038 10.1038/nrgastro.2013.171 10.1007/s12020-017-1323-4 10.1016/j.jcmgh.2018.01.003 10.1007/s12013-015-0682-9 10.1371/journal.pone.0052411 10.1002/hep.29914 10.1016/j.tox.2011.10.005 10.1016/j.clinre.2016.04.003 10.1124/jpet.107.122069 10.1002/bjs.5625 10.1124/jpet.105.087981 10.1016/S0168-8278(00)80219-6 10.1111/j.1600-0676.1987.tb00366.x 10.1152/ajpgi.00031.2015 10.1111/j.1365-2249.2012.04609.x 10.1016/j.taap.2004.12.018 10.1002/path.1917 10.1097/00042737-199602000-00008 10.1002/eji.201646394 10.1016/j.jhep.2013.12.005 10.1002/hep.25801 10.1111/j.1478-3231.2010.02284.x 10.1002/hep.21175 10.1016/j.cgh.2015.07.019 10.21037/atm-2020-90 10.1002/hep.25907 10.1186/s13046-015-0247-1 10.1016/j.jhep.2010.08.041 10.1158/0008-5472.CAN-05-1734 10.1038/nm.2084 10.1038/ncomms7818 10.1177/1076029618825310 10.1186/s13045-019-0836-0 10.3389/fimmu.2017.00464 10.1016/j.jhep.2017.11.010 10.1128/JVI.79.24.15142-15150.2005 10.4049/jimmunol.172.1.45 10.1152/ajplung.2000.279.6.L1005 10.1126/science.1099320 10.1089/ars.2007.1509 10.1161/01.HYP.0000196727.53300.62 10.1002/jlb.52.4.377 10.1002/hep.510290222 10.1155/2018/4780615 10.1016/0376-8716(91)90063-5 10.1016/j.jhep.2005.07.034 10.1016/j.jep.2010.01.043 10.1152/ajpgi.2000.278.5.G693 10.1002/hep.510250218 10.1016/j.fsi.2018.10.084 10.1016/j.taap.2010.08.025 10.1074/jbc.M701759200 10.1083/jcb.201203170 10.4049/jimmunol.1201719 10.1053/j.gastro.2019.03.013 10.1038/ncomms7673 10.1038/nm.2053 10.1371/journal.pone.0032366 10.1016/j.micinf.2003.09.008 10.1016/j.trsl.2010.02.003 10.1002/jlb.61.6.647 10.1083/jcb.107.6.2117 10.1002/jlb.59.5.716 10.2741/3462 10.1016/S0014-5793(03)00482-4 10.1152/ajpgi.00342.2002 10.1096/fj.03-0708fje 10.1023/A:1022344031223 10.1189/jlb.1012540 10.1111/imm.13005 10.1126/science.1195491 10.4049/jimmunol.1000332 10.1016/S0002-9440(10)61701-4 10.3389/fphys.2019.00006 10.1084/jem.20041035 10.1016/j.biocel.2015.02.017 10.1172/JCI119468 10.4049/jimmunol.173.12.7594 10.1084/jem.20071765 10.1002/hep.510290505 10.1182/blood.V80.8.2012.2012 10.1038/nrgastro.2017.183 10.1002/jlb.63.3.288 10.1152/ajpgi.00312.2005 10.1002/hep.510280324 10.1053/j.gastro.2009.12.008 10.1152/ajpgi.2001.281.5.G1188 10.1152/ajpgi.00318.2003 10.1046/j.1440-1746.2000.02207.x 10.1007/s10353-015-0363-3 10.1371/journal.pone.0032785 10.1111/jgh.14612 10.1016/j.coph.2011.06.007 10.1002/hep.510250324 10.1046/j.1440-1746.2000.02224.x 10.3748/wjg.v8.i2.342 10.1016/S0168-8278(97)80316-9 10.1111/j.1572-0241.1999.01541.x 10.1016/j.jhep.2012.09.008 10.1016/j.jhep.2019.02.012
Inflammation Wang Y, Liu Y

Mar 2nd, 2021 - Neutrophils are the most abundant type of leukocytes with diverse functions in immune defense including production of reactive oxygen species, bacteriocidal proteins, neutrophil extracellular traps, and pro-inflammatory mediators. However, aberran...

see more →

News  1,111 results

'CAP' Quantification of Liver Fat Not Reliable for Routine Use
https://www.medscape.com/viewarticle/945499

Feb 8th, 2021 - NEW YORK (Reuters Health) - Ultrasound-based controlled attenuation parameter (CAP), a noninvasive tool for assessment of hepatic steatosis, should be used with caution because while results are reliable in patients with viral hepatitis, that's no...

AGA Clinical Practice Update: Bariatric Surgery in Patients With Cirrhosis
https://www.medscape.com/viewarticle/945465

Feb 7th, 2021 - Obesity, a risk factor for nonalcoholic fatty liver disease (NAFLD) and a prevalent comorbidity among people with cirrhosis of all etiologies, is associated with a number of untoward health outcomes, and weight loss is an important goal, according...

Green-Enriched Mediterranean Diet Can Double Intrahepatic Fat Loss, Curb NAFLD
https://www.medscape.com/viewarticle/944660

Jan 26th, 2021 - NEW YORK (Reuters Health) - Following a Mediterranean diet (MED) enriched with protein-rich Mankai duckweed, green tea and walnuts and restricted in red and processed meat (green-MED) could double intrahepatic fat loss and reduce non-alcoholic fat...

Widespread Liver Disease Missed in Patients With Type 2 Diabetes
https://www.medscape.com/viewarticle/944609

Jan 24th, 2021 - Mounting evidence of strikingly high prevalence rates of fatty liver disease, advanced fibrosis, and cirrhosis among patients with type 2 diabetes has led to calls for heightened awareness and screening to identify these patients and target treatm...

Does the Ketogenic Diet Benefit Patients With Heart Failure?
https://www.medscape.com/viewarticle/943443

Jan 12th, 2021 - The ketogenic ("keto") diet, originally developed in the 1920s as an alternative treatment for pediatric epilepsy, remains a therapeutic strategy for a variety of conditions, including neurodegenerative diseases, diabetes, nonalcoholic fatty liver...

see more →

Patient Education  19 results see all →